原发肿瘤位置对乳腺浸润性导管癌根治术后患者预后的影响
回顾性分析993例接受改良根治术的乳腺浸润性导管癌患者,按原发肿瘤位置分组。中央区和内象限组5年DFS和OS显著低于外象限组,多因素分析显示中央区和内象限是独立不良预后因素。
要点
- 中央区和内象限原发肿瘤患者5年DFS和OS显著低于外象限患者。
- 中央区和内象限是根治术后乳腺浸润性导管癌的独立不良预后因素。
- 中央区患者肿瘤较大,内上象限患者术后接受内分泌治疗比例高。
核心结论
- 原发肿瘤位于中央区和内象限是改良根治术后乳腺浸润性导管癌患者的独立不良预后因素。
研究设计与样本
- 回顾性分析2008年1月至12月天津医科大学肿瘤医院993例接受改良根治术的乳腺浸润性导管癌患者,按原发肿瘤位置分组分析临床病理特征和预后。
主要发现
- 外上象限组556例(56.0%),外下象限组97例(9.8%),中央区组99例(10.0%),内上象限组186例(18.7%),内下象限组55例(5.5%)。
- 中央区组患者肿瘤较大,内上象限组患者术后接受内分泌治疗比例高。
- 5年无病生存率:外上象限组90.3%、外下象限组88.7%、中央区组79.8%、内上象限组86.0%、内下象限组72.7%,差异有统计学意义(P<0.001)。
- 5年总生存率:外上象限组97.5%、外下象限组96.9%、中央区组90.9%、内上象限组94.1%、内下象限组87.3%,差异有统计学意义(P<0.001)。
- 多因素分析显示中央区组、内上象限组和内下象限组患者的复发转移风险和死亡风险较其他组明显增加(P<0.001, P=0.002)。
临床怎么用
- 对于原发肿瘤位于中央区和内象限的乳腺浸润性导管癌患者,根治术后应加强随访和复发监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the clinicopathological features and prognosis of breast invasive ductal carcinoma patients receiving radical mastectomy according to the primary tumor location. Methods: From January 2008 to December 2008, 993 patients with breast invasive ductal carcinoma received radical mastectomy in Tianjin Medical University Cancer Institute and Hospital. Patients were grouped according to the primary tumor location when breast cancer was diagnosed. The clinicopathological characteristics and follow-up information of them was collected and analyzed retrospectively. Results: Of the 993 patients, primary tumor located in the upper-outer quadrant (UOQ) in 556 patients (56.0%), the lower-outer quadrant (LOQ) in 97 (9.8%), the central portion in 99 (10.0%), the upper-inner quadrant (UIQ) in 186 (18.7%), and the lower-inner quadrant (LIQ) in 55 (5.5%). Patients in the central portion tended to have larger tumors, and more patients in the upper-inner quadrant received endocrine therapy. The estimated 5-year disease-free survival (DFS) rates of patients with primary lesion in the UOQ, LOQ, central portion, UIQ and LIQ were 90.3%, 88.7%, 79.8%, 86.0% and 72.7%, respectively, with significant differences (P<0.001). The 5-year overall survival (OS) rates were 97.5%, 96.9%, 90.9%, 94.1% and 87.3%, respectively, with significant differences (P<0.001). Multivariate analysis showed that 5-year recurrence and metastasis risks were significantly increased in patients with primary lesion in the central portion, UIQ and LIQ compared to other groups (P<0.001), and 5-year mortality risks were increased in these three groups (P=0.002). Conclusion: Primary lesion located in central portion and inner quadrant is an independent adverse prognostic factor for patients with breast invasive ductal carcinoma patients receiving radical mastectomy. 目的: 探讨原发肿瘤位置对改良根治术后乳腺浸润性导管癌患者预后的影响。 方法: 收集2008年1月至2008年12月天津医科大学肿瘤医院收治的993例行改良根治术治疗的乳腺浸润性导管癌患者的临床病理资料和随访资料,根据诊断乳腺癌时不同原发肿瘤位置对患者进行分组,回顾性分析各组患者的临床病理特征和预后。 结果: 993例患者中,外上象限组556例(56.0%),外下象限组97例(9.8%),中央区组99例(10.0%),内上象限组186例(18.7%),内下象限组55例(5.5%)。中央区组患者肿瘤较大,内上象限组患者术后接受内分泌治疗比例高。外上象限组、外下象限组、中央区组、内上象限组和内下象限组患者的5年无病生存率分别为90.3%、88.7%、79.8%、86.0%和72.7%,差异有统计学意义(P<0.001),5年总生存率分别为97.5%、96.9%、90.9%、94.1%和87.3%,差异有统计学意义(P<0.001)。多因素分析显示,中央区组、内上象限组和内下象限组患者的复发转移风险和死亡风险较其他组明显增加(P<0.001, P=0.002)。 结论: 原发肿瘤位于中央区和内象限是根治术后乳腺浸润性导管癌患者的独立不良预后因素。.
引用
- Wang YT, Chen ZJ, Zhang D, et al. [Effect of the primary tumor location on the prognosis of breast invasive ductal carcinoma patients treated with radical mastectomy]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31550859. doi:10.3760/cma.j.issn.0253-3766.2019.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。